GlaxoSmithKline (GSK) Acquires Sirtris Pharmaceuticals (SIRT) for $720 Million
Tweet Send to a Friend
GlaxoSmithKline (NYSE: GSK) has completed its acquisition of Sirtris Pharmaceuticals, Inc. (Sirtris) for approximately US$720 million through a cash tender ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
